Local administration of interleukin-11 ameliorates intestinal radiation injury in rats

Cancer Research

Volumn 67, Issue 19, 2007, Pages 9501-9506

  Boerma, Marjan ^a   Wang, Junru ^b   Burnett, Alexander F ^b   Santin, Alessandro D ^b   Roman, Juan J ^b   Hauer Jensen, Martin ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 11; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; ILEOSTOMY; INTESTINE WALL; INTRALUMINAL DRUG ADMINISTRATION; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION ENTEROPATHY; RAT; SCROTUM; SPRAGUE DAWLEY RAT;

ANIMALS; HUMANS; INTERLEUKIN-11; INTESTINAL DISEASES; INTESTINES; MALE; MAST CELLS; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 35148825511     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0810     Document Type: Article

References (41)

1. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 2005;54:1051-4.
2. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100:1995-2025.
3. Richter KK, Wang J, Fagerhol MK, Hauer-Jensen M. Radiation-induced granulocyte transmigration predicts development of delayed structural changes in rat intestine. Radiother Oncol 2001;59:81-5.
4. Johnson LB, Riaz AA, Adawi D, et al. Radiation enteropathy and leucocyte-endothelial cell reactions in a refined small bowel model. BMC Surg 2004;4:10.
5. Denham JW, Hauer-Jensen M. The radiotherapeutic injury - a complex 'wound'. Radiother Oncol 2002;63:129-45.
6. Langberg CW, Hauer-Jensen M, Sung CC, Kane CJ. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 1994;32:29-36.
7. Kawashima R, Kawamura YI, Kato R, et al. IL-13 receptor α2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice. Gastroenterology 2006;131:130-41.
8. Boerma M, Wang J, Richter KK, Hauer-Jensen M. Orazipone, a locally acting immunomodulator, ameliorates intestinal radiation injury: a preclinical study in a novel rat model. Int J Radiat Oncol Biol Phys 2006;66:552-9.
9. Schwertschlag US, Trepicchio WL, Dykstra KH, et al. Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 1999;13:1307-15.
10. Ropeleski MJ, Tang J, Walsh-Reitz MM, Musch MW, Chang EB. Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology 2003;124:1358-68.
11. Tepler I, Elias L, Smith JW, et al. Arandomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996;87:3607-14.
12. Sands BE, Winston BD, Salzberg B, et al. Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease. Aliment Pharmacol Ther 2002;16:399-406.
13. Du XX, Doerschuk CM, Orazi A, Williams DA. Ab one marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 1994;83:33-7.
14. Potten CS. Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells 1996;14:452-9.
15. Booth D, Potten CS. Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr 2001;2001:16-20.
16. Dykstra KH, Rogge H, Stone A, et al. Mechanism and amelioration of recombinant human interleukin-11 (rhIL-11)-induced anemia in healthy subjects. J Clin Pharmacol 2000;40:880-8.
17. Antin JH, Lee SJ, Neuberg D, et al. A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. Bone Marrow Transplant 2002;29:373-7.
18. Cotreau MM, Stonis L, Strahs A, Schwertschlag US. Amultiple-dose , safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin). Biopharm Drug Dispos 2004;25:291-6.
19. Guo HL, Wolfe D, Epperly MW, et al. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg 2003;7:229-35.
20. Hauer-Jensen M, Poulakos L, Osborne JW. Effects of accelerated fractionation on radiation injury of the small intestine: a new rat model. Int J Radiat Oncol Biol Phys 1988;14:1205-12.
21. Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M. Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol 1996;35:81-7.
22. Baddeley AJ, Gundersen HJ, Cruz-Orive LM. Estimation of surface area from vertical sections. J Microsc 1986;142:259-76.
23. Wang J, Zheng H, Sung CC, Richter KK, Hauer-Jensen M. Cellular sources of transforming growth factor-β isoforms in early and chronic radiation enteropathy. Am J Pathol 1998;153:1531-40.
24. Trepicchio WL, Wang L, Bozza M, Dorner AJ. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J Immunol 1997;159:5661-70.
25. Peterson RL, Wang L, Albert L, Keith JC, Jr., Dorner AJ. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest 1998;78:1503-12.
26. Rodemann HP, Binder A, Burger A, et al. The underlying cellular mechanism of fibrosis. Kidney Int Suppl 1996;54:S32-6.
27. Barcellos-Hoff MH. How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res 1998;150:S109-20.
28. Zheng H, Wang J, Koteliansky VE, Gotwals PJ, Hauer-Jensen M. Recombinant soluble transforming growth factor β type II receptor ameliorates radiation enteropathy in mice. Gastroenterology 2000;119:1286-96.
29. Orazi A, Du X, Yang Z, Kashai M, Williams DA. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 1996;75:33-42.
30. Wang RJ, Peng RY, Fu KF, et al. Effect of recombinant human interleukin-11 on expressions of interleukin-11 receptor α-chain and glycoprotein 130 in intestinal epithelium cell line-6 after neutron irradiation. World J Gastroenterol 2006;12:3055-9.
31. Peterson RL, Bozza MM, Dorner AJ. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol 1996;149:895-902.
32. Potten CS, Booth D, Haley JD. Pretreatment with transforming growth factor β-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 1997;75:1454-9.
33. Gyotoku E, Morita E, Kameyoshi Y, et al. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice. Arch Dermatol Res 2001;293:508-14.
34. Zheng H, Wang J, Hauer-Jensen M. Role of mast cells in early and delayed radiation injury in rat intestine. Radiat Res 2000;153:533-9.
35. Stead RH. Innervation of mucosal immune cells in the gastrointestinal tract. Reg Immunol 1992;4:91-9.
36. Venkova K, Keith JC, Jr., Greenwood-Van Meerveld B. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats. J Pharmacol Exp Ther 2004;308:206-13.
37. Wang J, Zheng H, Kulkarni A, Ou X, Hauer-Jensen M. Regulation of early and delayed radiation responses in rat small intestine by capsaicin-sensitive nerves. Int J Radiat Oncol Biol Phys 2006;64:1528-36.
38. Yamazumi K, Nakayama T, Kusaba T, et al. Expression of interleukin-11 and interleukin-11 receptor α in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors. World J Gastroenterol 2006;12:317-21.
39. Deutscher N, Bataille F, Hausmann M, et al. Functional expression of the interleukin-11 receptor α-chain in normal colonic epithelium and colon cancer. Int J Colorectal Dis 2006;21:573-81.
40. Booth C, Potten CS. Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 1995;28:581-94.
41. Redlich CA, Gao X, Rockwell S, Kelley M, Elias JA. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 1996;157:1705-10.